Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Thomas J Pittman who wrote (6707)	7/17/1998 10:12:00 PM
From: aknahow	Respond to of 17367

Tom, he might have know but even before the Incyte deal XOMA's patent position was very solid. Received my first copy of Prohost. Think it's current but called June/July. Has stock quotes as of July 7. Full page and a tad more on XOMA. Nothing posters here don't know but a very nice job. Ends with, " Investors ask us, why, despite the good news, XOMA's stock does not appreciate? We say: Don't you see that the same is happening to biotech stocks across the board no matter what the news about them is? Why should we bother to know why short-term traders sell or buy stocks? What we really care about is making sure that our knowledge of the biotech fundamentals will allow us to value the firms accurately and correctly. As for the market, if it is always correct, it should have no reason to correct. But the fact is that it frequently does."